title: Human aromatase: gene resequencing and functional genomics.
abstract: Aromatase [cytochrome P450 19 (CYP19)] is a critical enzyme for estrogen biosynthesis, and aromatase inhibitors are of increasing importance in the treatment of breast cancer. We set out to identify and characterize genetic polymorphisms in the aromatase gene, CYP19, as a step toward pharmacogenomic studies of aromatase inhibitors. Specifically, we "resequenced" all coding exons, all upstream untranslated exons plus their presumed core promoter regions, all exon-intron splice junctions, and a portion of the 3'-untranslated region of CYP19 using 240 DNA samples from four ethnic groups. Eighty-eight polymorphisms were identified, resulting in 44 haplotypes. Functional genomic studies were done with the four nonsynonymous coding single nucleotide polymorphisms (cSNP) that we observed, two of which were novel. Those cSNPs altered the following amino acids: Trp39Arg, Thr201Met, Arg264Cys, and Met364Thr. The Cys264, Thr364, and double variant Arg39Cys264 allozymes showed significant decreases in levels of activity and immunoreactive protein when compared with the wild-type (WT) enzyme after transient expression in COS-1 cells. A slight decrease in protein level was also observed for the Arg39 allozyme, whereas Met201 displayed no significant changes in either activity or protein level when compared with the WT enzyme. There was also a 4-fold increase in apparent K(m) value for Thr364 with androstenedione as substrate. Of the recombinant allozymes, only the double mutant (Arg39Cys264) displayed a significant change from the WT enzyme in inhibitor constant for the aromatase inhibitors exemestane and letrozole. These observations indicate that genetic variation in CYP19 might contribute to variation in the pathophysiology of estrogen-dependent disease.
authors.affiliation: Department of Medical Oncology, Mayo Clinic College of Medicine, Rochester, Minnesota 55905, USA.
authors.forename: Cynthia X
authors.initials: CX
authors.lastname: Ma
authors.forename: Araba A
authors.initials: AA
authors.lastname: Adjei
authors.forename: Oreste E
authors.initials: OE
authors.lastname: Salavaggione
authors.forename: Josefa
authors.initials: J
authors.lastname: Coronel
authors.forename: Linda
authors.initials: L
authors.lastname: Pelleymounter
authors.forename: Liewei
authors.initials: L
authors.lastname: Wang
authors.forename: Bruce W
authors.initials: BW
authors.lastname: Eckloff
authors.forename: Daniel
authors.initials: D
authors.lastname: Schaid
authors.forename: Eric D
authors.initials: ED
authors.lastname: Wieben
authors.forename: Alex A
authors.initials: AA
authors.lastname: Adjei
authors.forename: Richard M
authors.initials: RM
authors.lastname: Weinshilboum
mesh_terms: D000483:Alleles; D000818:Animals; D001141:Aromatase / Q000235:genetics* / Q000378:metabolism*; D047072:Aromatase Inhibitors / Q000378:metabolism / Q000494:pharmacology; D015153:Blotting, Western; D019556:COS Cells; D002522:Chlorocebus aethiops; D004247:DNA / Q000235:genetics; D023281:Genomics; D006239:Haplotypes; D006801:Humans; D007700:Kinetics; D015810:Linkage Disequilibrium; D020641:Polymorphism, Single Nucleotide; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000235:genetics; D013347:Subcellular Fractions / Q000378:metabolism
chemical_list: D047072:Aromatase Inhibitors; D011994:Recombinant Proteins; D004247:DNA; D001141:Aromatase